Intrahepatic cholangiocellular carcinomas (ICCs) are usually fatal neoplasms originating from bile duct epithelia. However, many cholangiocarcinoma cells are shown to be resistant to chemotherapeutic drugs, which induce cell apoptosis. The role of autophagy and the therapeutic value of autophagy-associated genes are largely unknown in ICC. Here, we showed that autophagy was activated in nutrient starvation and xenograft cholangiocarcinoma cells. Furthermore, expression of autophagic genes and their autophagic activity were higher in clinical ICC specimens than that in normal cholangiocytes separated by laser capture microdissection. Inhibition of autophagy by autophagy inhibitors or siRNA, cholangiocarcinoma cells showed detention of proliferation and increase of apoptosis during nutrient starvation. In addition, autophagy inhibitor treatment or knockdown of beclin 1 suppressed tumor growth and sensitized ICC cells to chemotherapeutic agent-induced cell death. In conclusion, our data showed that autophagy is activated in ICC, and inactivation of autophagy may lead to cell apoptosis and enhance chemotherapy sensitivity. Intrahepatic cholangiocellular carcinoma (ICC) is a malignant neoplasm originating from epithelium of the biliary tree with high mortality.
Intrahepatic cholangiocellular carcinoma (ICC) is a malignant neoplasm originating from epithelium of the biliary tree with high mortality. 1 ICC accounts for 5-30% of all primary liver malignancies, and its incidence has been increasing over the last several decades. 2 The mortality from intrahepatic cholangiocarcinoma is very high, with the 5-year survival rates being o15-20% in most series. 3, 4 However, the exact molecular mechanisms of biliary epithelium malignant transformation are not well understood. Despite improved diagnostic and operative techniques, the prognosis of ICC remains poor. 5 Indeed, ICC is a type of cancer highly resistant to conventional antineoplastic medicines, 4 which is partially attributed to the property of insensitivity to cell death induced by cytotoxic agents. It is well known that the avoidance of apoptosis is one of the hallmarks of cancer cells, 6 and that failure to induce apoptosis by anticancer treatments contributes to chemotherapeutic failure and tumor progression. Although autophagy, an alternative caspase-independent cell death program, 7 is thought to be used for cancer treatment, its underlying molecular mechanism is still controversial in antineoplastic therapy and also in tumor progression. Autophagy is a conserved catabolic process by which cells themselves digest their organelles. 8 Autophagy has emerged as a homeostatic mechanism regulating the turnover of long-lived or damaged proteins and organelles, and buffering metabolic stress induced under starvation conditions by recycling intracellular constituents. 9 Autophagosomes engulfing organelles then fuse with lysosomes and mature into autolysosomes. Autophagic processes have been well characterized in yeast, and 430 autophagy-related genes that encode the proteins executing autophagy have been identified in the field of yeast genetics. 6, 7 The amino acids and fatty acids generated by autophagic degradation are used by the tricarboxylic acid cycle to produce ATP. Although previous findings strongly suggest that autophagy contributes to sustainable cell survival, antitumorigenic roles of autophagy have been also mentioned. 8 Autophagy has roles in protecting cells against shortage of nutrients. Cells supply amino acids from self-digested organelles as an alternative energy source for their survival. 6, 9 This function of autophagy seems ideal to foster cancer cells to survive in an unfavorable starved environment. However, the physiologic relevance of autophagy in tumor formation and progression is still not clear. Although activation of autophagy is in multiple human primary cancers, the biological role of autophagy in control of cholangiocarcinoma growth has not been established. In this study, we performed in vitro and in vivo studies to address the role of autophagy in cholangiocarcinoma cell growth, apoptosis and chemotherapy sensitivity by molecular inhibitors and antisense depletion of autophagy essential gene expression, intercepting regular autophagy process, to evaluate the role of autophagy in the effect of chemotherapy of human intrahepatic cholangiocarcinoma.
MATERIALS AND METHODS Cell Lines
Human cholangiocarcinoma cell lines QBC939, RBE and HCCC9810 cells were purchased from XiangYa Central Experiment Laboratory and cultured in RPMI1640 medium supplemented with 15% NCS (Gibco, 16010-159). The cholangiocarcinoma cell lines RBE and HCCC9810 are both derived from intrahepatic cholangiocarcinoma, 10,11 while QBC939 is derived from hilar. 12 For starvation studies, these three cell lines were seeded in 12-well plates and incubated in medium without amino acids. The cells were then washed with PBS, and cultured in Earle's Balanced Salt Solution (EBSS; Sigma-Aldrich, E2888) at 37 1C for the indicated times.
Reagents
Wortmannin and 3-methyl adenine (3-MA) were purchased from Sigma (W1628, M9281). Wortmannin was used at 5 mM and 3-MA was used at 10 mM. 13, 14 Cisplatin and doxorubicin were purchased from Shandong Qilu Pharmaceutical Product Factory (H37021358, H33021980). Cisplatin concentration was 6 mg/ml and doxorubicin was used at 10 mg/ml. 15, 16 Hoechst 33342 and propidium iodide (PI) were purchased from Sigma (14533, P4170).
Patients Samples
The 41 primary intrahepatic cholangiocarcinoma specimens used in real-time PCR studies were randomly collected from the patients undergoing curative resection in Eastern Hepatobiliary Surgery Hospital in Shanghai, China from 2002 to 2007. The specimens used for immunohistochemistry (IHC) were routinely processed, formalin fixed and paraffin embedded. Twenty-four frozen tissue samples from above patients were used for western analysis and 50 cases for IHC assay. Five of normal bile vessel tissue were obtained by laser capture microdissection from frozen angioma specimens as described before. 17 Informed consent was obtained from all patients before subsequent use of their resected tissues. The present study was performed in accordance with the ethical standards of the Helsinki Declaration in 1975, after approval of the local ethics committee.
Production of Recombinant Adenovirus and Adenoviral Infection
Production of recombinant adenovirus methods is as described previously. 18 The synthesized oligonucleotides were as follows: Sibeclin1 forward, 5 0 -GATCCCCCAGTTTGGCAC AATCAATATTCAAGAGATATTGATTGTGCCAAACTGTTTT TA-3 0 ; reverse, 5 0 -AGCTTAAAAACAGTTTGGCACAATCA ATA TCTCTTGAATATTGATTGTGCCAAACTGGGG-3 0 .
RNA Isolation and Real-Time PCR Total RNA was extracted from frozen specimens using Trizol Reagent (Invitrogen, 15596-026). Total RNA (2 mg) was used for RT with oligo(dT) random primers of Promega RT kit according to the manufacturer's protocol. All quantitative real-time PCR reactions were performed in 1 Â Universal Master Mix (Applied Biosystems, 4367659) with gene-specific primers and probe on the ABI Prism 7300 Sequence Detection System, according to the manufacturer's instructions. The 18 S rRNA levels were quantified as internal control to normalize the expression of each gene. Each reaction was repeated independently at least three times.
Western Blotting Assay
Western blotting was performed as previously described. 19 In brief, the tissues or cells were lysed in RIPA buffer and sonicated. Protein concentrations were measured by BCA (Thermo scientific, 23228). Proteins were loaded to standard SDS-PAGE gel and transferred to polyvinylidene difluoride membranes, which were detected with the primary antibodies: anti-LC3 rabbit polyclonal (dilution, 1:1000; Abcam, ab48394); anti-beclin 1 monoclonal (dilution, 1:1000; Santa Cruz, sc-48381); anti-Tubulin monoclonal (Santa Cruz, sc-58667) and anti-GADPH monoclonal (dilution, 1:1000; Cell Signaling, 2118), followed by a secondary antibody (IRDye800CW, 926-32210). The fluorescence density on PVD membranes were detected with LI-COR imaging system (LI-COR Biosciences, 9201-01).
Immunohistochemistry
Sections were deparaffinized through xylene and rehydrated with graded alcohol. Endogenous peroxidase was then blocked with 3% H 2 O 2 diluted in methanol for 20 min at room temperature. Antigen retrieval was performed by treating the slide in citrate buffer in a microwave for 10 min. The slides were blocked in 1% bovine serum albumin and incubated with beclin 1 monoclonal antibody (Santa Cruz, sc-48381) at 4 1C overnight. After a brief wash in PBS, the slides were treated with goat anti-mouse (Santa Cruz, sc-2031) for 30 min at 37 1C. After a brief wash in PBS, the slide was developed in 0.05% freshly prepared diaminobenzedine solution (DAB, Sigma, D8001) for 8 min, and then counterstained with hematoxylin.
Cell Proliferation, Cycle and Apoptosis Analysis Cell proliferation was detected by CCK-8 assay. Cells were seeded (5 Â 10 3 cells per well) in 96-well plates and cultured overnight at 37 1C, then exposed to drugs for indicated time and cell viability was measured using Cell Counting kit-8 at various time points according to the guidance of the manufacturer. Cell cycle analysis was assessed by staining with PI as described previously. 20 Hoechst 33342 was applied to detect nuclear fragmentation characteristic of apoptosis as described previously. 21 Treated cells were stained and examined under fluorescent microscopy. Apoptosis was also assessed by using an AnnexinV-FITC apoptosis detection kit (Invitrogen, V13241) according to the manufacturer's protocol.
Detection of the Expression of Green Fluorescent Protein-LC3
The green fluorescent protein (GFP)-human LC3 fusion protein expressing plasmid pEGFP-LC3 was kindly provided by Prof. Mujun Zhao (Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, People's Republic of China). QBC939 and RBE cells (5 Â 10 4 per well) were seeded in six-well plates the day before transfection and 2 mg of plasmid was transfected with FuGENER HD Transfection Reagent (Roche, 04709691001). GFP fusion proteins were observed under a laser scanning microscope system (PerkinElmer, UltraVIEWVoX). The percentage of GFP-LC3-positive cells with GFP-LC3 punctate dots was determined from three independent experiments. The cells with more than five GFP-LC3 punctate dots were counted under blinded conditions. A minimum of 30 GFP-LC3-positive cells assessed from at least six random fields per sample were counted in triplicate per condition per experiment.
Transmission Electron Microscopy
Surgically resected tissue samples were fixed in ice-cold 2% glutaraldehyde and examined with a JEOL transmission electron microscope (JEM-1230) as described previously. 22 
Xenograft Tumor Model in Nude Mice
The xenograft model was described as before. 23 The QBC939 cells were grown to subconfluency in complete medium. Viable cells (2 Â 10 6 in PBS/100 ml) were injected subcutaneously into the flanks of 4-week-old nude mice. Two weeks after tumor cell inoculation, mice were divided randomly into groups and were given i.p. injections of either the drug vehicle DMSO (Sigma, D8414) or wortmannin (2 mg/ kg) 24, 25 for 10 days or treated AdSi-beclin or AdSi-blank virus for 2 weeks by a way of multiple-center intratumor injection of 50 ml. Then, all mices were killed and the xenografted tumors were excised. All animals received human care according to the criteria outlined in the Guide for the Care and Use of Laboratory Animals, which was prepared by the National Academy of Sciences and published by the National Institutes of Health (publication 86-23; revised 1985).
Statistical Analysis
The data were expressed as means±s.d. Statistical analysis was performed by using Student's t-test or by one-way ANOVA followed by Dunnett's test for multiple comparisons. P-value o0.05 was considered significant.
RESULTS

Nutrient Starvation and Xenograft-Induced Autophagy Activation in Cholangiocarcinoma Cell Lines
Three cholangiocarcinoma cell lines, including QBC939, RBE and HCCC9810, were used to examine autophagy activation in nutrient starvation situation. These cells were cultured in amino-acid-deprived medium with or without the combination of 3-MA for 12 h. The distribution of GFP-LC3 was determined by confocal fluorescent microscopy, and autophagosome-associated GFP-LC3 level was quantified ( Figure 1a) .
The GFP-LC3 fusion protein was observed as coarse dots in the cytoplasm of both QBC and RBE cells cultured in an amino-acid-deprived medium. While adding, 3-MA significantly inhibited GFP-LC3 dots formation in starvation cells. LC3-II was detected in cells cultured in amino-aciddeprived medium for 6, 12, 24, 36 and 48 h. We found that the levels of LC3-II were significantly increased in cells from 12 h in amino-acid deprivation condition compared with non-starvation (Figure 1b) . We then asked whether increased level of autophagy is also seen in cholangiocarcinoma during these cells form tumor in mice. We injected the three cell lines subcutaneously into flanks of nude mice, but only QBC cells can form tumor. In the QBC tumor, the ultrastructures of autophagy (autophagic vesicles) were visualized as double-membrane vacuoles in the cytoplasm under the transmission electron microscopy (Figure 1cB and C), while in the free QBC cells few vacuoles was detected (Figure 1cA ). The results indicated that nutrition deprivation may induce activation of autophagy that is involved in tumorigenesis.
Autophagy Is Activated in Clinical Cholangiocarcinoma Specimen
To investigate whether autophagy is also present in cholangiocarcinoma of patients, we detected autophagy in surgically resected cholangiocarcinoma tissues by transmission electron microscopy. The results revealed that there was rare vacuoles in normal bile duct epithelium (Figure 2aA ) compared with ICC tissue (Figure 2aB and C) . Large membranous vacuoles were seen in the cytoplasm and some of the vacuoles resembled autophagosomes and contained remnants of degraded organelles, including mitochondria ( Figure 2a ). Next, we tested expression of full-length LC3-I and LC3-II using lysates from cholangiocarcinoma specimens. We found that 18 out of 24 cases presented high LC3-II expression (Figure 2b) . The mRNA expression of autophagic relative genes (atg5, beclin 1) was evaluated in 41 primary intraheptic cholangiocarcinoma specimens. Almost all the autophagy genes were observed in higher mRNA levels compared with normal cholangiocytes separated by laser capture microdissection. As shown in the results (Figure 2c ), beclin1 mRNA expression was markedly increased in 85% (35 of 41) samples. The atg5 highly expressed in about 88% (36 of 41) of samples (Figure 2c) . IHC was performed on beclin 1 expression in 50 cases of ICC samples. As shown in Figure 2d , 28% (14 of 50) of samples presented strong expression, 48% (24 of 50) presented moderate expression and 24% (12 of 50) showed none to weak expression. We also detected beclin 1 expression in normal liver tissues and found all the samples presented none to weak expression in bile duct epithelium (Figure 2d ).
Inhibition of Autophagy-Induced Apoptosis of Cholangiocarcinoma Cell Lines During Nutrient Starvation
To examine the effect of autophagy on tumor cell survival during nutrient starvation, we observed whether inhibition of autophagy would affect tumor growth. We found that QBC939 and RBE cells showed few apoptotic cells in both cell lines during 48 h culture in amino-acid-deprived medium, which was detected by Hoechst33342 staining (Figure 3a and b) . On the contrary, when the autophagy inhibitor, 3-MA, was applied to amino-acid-deprived medium, there were more chromatin condensation occurring in these cells (Figure 3a and b), which was also confirmed with AnnexinV and PI double staining (Figure 3c and d) . 
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In mammalian, beclin1 is a part of class-III PI3K complex, which is required to recruit the Atg12-Atg5 conjugate to the preautophagosomal structure. In all, 3-MA, as an inhibitor against this conjunction at a relatively early stage, attenuates autophagy. Then, we construct the (adnovirus-delivered) AdSiRNA targeting beclin 1 to block the formation of autophagosomes. In QBC939 cells, the Adsibeclin significantly decreased the expression of beclin 1 mRNA and protein (Figure 4a) . By CCK-8 assay, we determined the proliferation of QBC cells after transfection with AdSi-beclin or AdSi-blank virus for 12 h. The results showed that knocking down beclin 1 caused cells growing slowly compared with cells with normal expression of beclin 1 (Figure 4b ). Flow cytometry revealed that QBC cells with downregulation of beclin 1 arrested at G2/M phase under starvation condition (Figure 4c ). These results suggest that autophagy is involved in regulation of cell proliferation and cycle. We used AnnexinV-FITC and PI staining assay to determine the apoptotic cell death under normal culture medium or EBSS starvation medium. As shown in Figure 4d , QBC cells infected with blank adenovirus showed no difference in the number of apoptoic cells in normal or EBSS medium (4.88% vs 5.87%). To our surprise, deletion of beclin 1 did not result in increase of apoptotic cells in cells in normal culture medium, but gave rise to more apoptotic cells when the cells were in EBSS starvation medium (5.87% vs 11.71%), suggesting that beclin 1 is involved in regulating cell apoptosis in starvation condition.
Inhibition of Autophagy Suppressed Established Tumor Growth in Nude Mice
To determine whether the autophagy inhibitors could serve as a therapeutic agent against cholangiocarcinoma tumor formation, 2 weeks after inoculation of the cells, DMSO or wortmannin was administered. After treatment with the agent for 2 weeks, the tumor growth obviously was inhibited compared with the DMSO animal group (Figure 5a ). The weight of tumors in DMSO group was almost two times than that in wortmannin group (Figure 5b) . By real-time PCR assay, wortmannin treatment decreased atg5 and beclin1 expression in the QBC tumors (Figure 5c and d) . We also used AdSi-beclin or AdSi-blank virus to administer locally by intratumor injection. This kind of treatment causes significant suppression of beclin 1 expression, which was confirmed by the immunostaining on tumor slices (Figure 5g) . Furthermore, we stained the tumor specimen for cholangiocyte marker CK19, as shown in Figure 5g , the xenograft tumor cells retained cholangiocytes. After treatment with AdSi-beclin, the tumor growth obviously was inhibited compared with the AdSi-blank or mock animal group (Figure  5e and f).
Inhibition of Autophagy Enhances Sensitivity of Cholangiocarcinoma Cells to Chemotherapy
Cisplatin is reported to have an additive or synergistic effect in combination with other drugs in a number of different tumor types, including biliary tract carcinoma. 26 Fluorescence microscopy revealed a diffuse localization of GFP-LC3 in PBS-treated control cells. In contrast, treatment of cells with cisplatin produced a punctate pattern for GFP-LC3 fluorescence (Figure 6a ), indicating that LC3-II were recruited to autophagosomes during activation of autophagy. The results were confirmed by analysis of LC3 expression in cell lysates, revealed the presence of processed LC3-II that was evident as early as 6 h post-treatment with doxorubicin or cisplatin and its intensity increased with longer stimulating time (Figure 6b) .
In order to examine if the activated autophagy could affect the chemotherapy effects on cholangiocarcinoma cells, we detected the proliferation of cholangiocarcinoma cells in the treatment of cisplatin with or without autophagy inhibitors by CCK-8 assay. Proliferation assay showed that treatment with cisplatin alone did not inhibit proliferation of the two cholangiocarcinoma cells (Figure 6c and d) , while treatment combined with 3-MA or wortmannin significantly suppressed the growth of cholangiocarcinoma cells. To confirm these results, we reexamined the proliferation tests by directly measuring the number of cells. As shown in Supplementary  Figure, 3 -MA combined with cisplatin treatment significantly inhibited cell proliferation. These results suggest that inhibition of autophagy is helpful for cisplatin-induced suppression of proliferation. 
DISCUSSION
In the present study, we demonstrate that the role of autophagy in ICC cells is important in the condition of nutrient starvation and chemotherapy. Human intrahepatic cholangiocarcinomas have shown high expression of autophagy genes and proteins.
Increasing evidence indicates that autophagy is the presence and active in various of tumor cells and promotes tumor cell survival in response to starvation, hypoxia, oxidative damage or other stress. [27] [28] [29] [30] Hepatitis B virus and hepatitis C virus infections, liver cirrhosis and other inflammation diseases have been examined as potential risk factors for ICC, 31, 32 and also potential factors for induction of autophagy. During growth of ICC, tumor cells periodically outstrip in the vasculature, resulting in narrowing blood vessels that causes nutrient starvation and low oxygen. Our results determine that nutrition starvation is able to activate formation of autophagy and expression of its associated proteins, such as LC3-II, beclin 1. Function of autophagy is thought to be a self-digestive process that ensures lysosomal degradation of long-lived proteins and organelles to maintain cellular homeostasis, 6 and may be as a protective mechanism and an indispensable physiologic reaction for cells to survive and generate nutrients and energy. 33 But many studies demonstrated that persistent stress can also promote autophagic cell death. 34, 35 Autophagy-induced cell death eliminates damaged and harmful cells, such as cancer cells treated with anticancer reagents or the cells infected with pathogenic microorganisms. 8, 33, 35 However, the role of autophagy in cancer remains elusive. In this paper, we put cells in a condition deprived amino acids that mimics tumor microenvironment relatively lacking of nutrition. The results appear that nutrition starvation increased autophagy formation and did not lead cells undergo apoptosis. But inhibition of autophagy promotes apoptosis, suggesting that autophagy may be supportive for development and survival of ICC cells in a state with relative lack of nutrition.
The beclin 1 gene is monoallelically deleted in 40-75% of sporadic breast, prostate and ovarian tumors. [36] [37] [38] Previous studies have shown that beclin 1 can function as a negative regulator of mammary cell growth and tumorigenesis as well as in the induction of autophagy in breast cancer cells. 39 Decreased expression of beclin 1 has also been demonstrated in some human cancers, including glioblastomas, ovarian cancers and esophageal cancers. [39] [40] [41] However, increased expression of beclin 1 has been reported in colorectal and gastric cancer cells as compared with the normal counterparts. 42 In this study, we found that beclin 1 mRNA was marked highly expression in 85% clinical ICC samples and 76% cases showed high protein expression. These discrepant results suggest that beclin 1 has different expression pattern in different tissues.
Since option of chemotherapy treatment for cholangiocarcinoma is limited, conventional chemotherapy and radiation therapy to date have been proved to be ineffective in improving long-term survival. Currently, complete resection of the tumor is the only best choice for long-term survival. Unfortunately, the vast majority of patients with cholangiocarcinoma don't have optimal situation for curative surgery when diagnosis is confirmed. Patients with resection generally have the higher recurrence rate. 43, 44 In addition, chemotherapy also induces acquired resistance that has been one of the most important clinical problems. 45, 46 At such a circumstance, there is now a real and urgent need to focus on developing novel therapeutic strategies for cholangiocarcinoma that would impact in a significant way on clinical outcome. We used cisplatin and doxorubicin, the two clinically highly relevant anticancer drugs, to stimulate cholangiocarcinoma cells and observed that autophagy was activated. Cisplatin is a clinically highly relevant anticancer drug used for the treatment of many kinds of cancers. The major mechanism underlying its antitumor activity has been ascribed to the induction of DNA damage by platinum compounds. 47 Doxorubicin is also known to interact with DNA by intercalation and inhibition of macromolecular biosynthesis. 48 Question is whether the activated autophagy contributes to chemotherapy resistance? By autophagy inhibitor and adenovirus-delivered siRNA for autophagy protein, beclin 1, to block autophagy activation, we found that these treatments promote sensitivity of the cells to chemotherapy drug, resulting in more apoptotic cells than control. This study is the first time to demonstrate that DNA-damaging chemotherapeutic drugs, cisplatin and doxorubicin, activate an autophagic stress response in the cholangiocarcinoma cells. This work also showed that knocking down of proteins, such as beclin 1, is critical for autophagosome formation, and may lead to apoptosis occurring in these cells.
In conclusion, our paper demonstrates that nutrient starvation induces autophagy activation that promotes xenograft tumor formation of cholangiocarcinoma cells. Inhibition of autophagy by autophagy inhibitor or siRNA, ICC cells show inhibition of proliferation and increase of apoptosis during (g) QBC cells were infected as mentioned above, and then were treated with cisplatin (6 mg/ml) for 48 h. The cells were stained and apoptosis was assessed by flow cytometry. *Po0.05; **Po0.01 (n ¼ 3).
